Skip to main content

Table 1 demographic and baseline characteristics of the patients

From: Impact of parathyroidectomy on left ventricular function in end stage renal disease patients

CHARACTERISTIC

NUMBER

Sex

 Male

81(60.0%)

 Female

54 (40.0%)

Age

45.60 ± 1.0 year

Dialysis duration

6.45 (5.0,9.0) year

Dialysis modality

 PD

12 (8.9%)

 HD

121 (89.6%)

 ESRD without dialysis

2 (1.5%)

Primary disease

 CGN

108 (80%)

 Polycystic kidney

10 (7.4%)

 Hypertensive nephropathy

5 (3.7%)

 Diabetic nephropathy

4 (3.0%)

 Others

8 (5.9%)

The number of parathyroid gland

 <4

16 (11.9%)

  ≥ 4

119 (88.1%)

Blood pressure

 Pre-PTX systolic pressure (mmHg)

139.4 ± 22.8

 Pre-PTX diastolic pressure (mmHg)

88.6 ± 15.4

 1-year post-PTX systolic pressure (mmHg)

144.5 ± 23.5

 1-year post-PTX diastolic pressure (mmHg)

80.1 ± 13.3

cardiovascular drugs used during the follow-up

 ACEI

5 (3.7%)

 ARBs

30 (22.2%)

 calcium blockers

50 (37.0%)

 cardiotonics

1 (0.7%)

 β-blockers

48 (35.6%)

 isosorbide mononitrate

11 (8.1%)

 trimetazidine

8 (5.9%)

  1. PD peritoneal dialysis, HD: hemodialysis, ESRD End Stage Renal Disease, CGN chronic glomerulonephritis, ACEI angiotensin-converting enzyme inhibitors, ARBs angiotensin receptor blockers